Cytochrome P450 Enzymes
Cytochrome P450 Enzymes - Related Videos
01:28
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
0 Views •
2026
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
07:42
Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
0 Views •
Cited by 15 •
2011
In this protocol, we describe the direct cytoplasmic microinjection of cytochrome c protein into fibroblasts and primary sympathetic neurons. This technique allows for the introduction of cytochrome c protein into the cytoplasm of cells and mimics the release of cytochrome c from mitochondria, which occurs during apoptosis.
11:06
Encapsulating Cytochrome c in Silica Aerogel Nanoarchitectures without Metal Nanoparticles while Retaining Gas-phase Bioactivity
0 Views •
Cited by 1 •
2016
This procedure describes how to encapsulate cytochrome c (cyt. c) in silica (SiO2) sol-gels, process these gels to form bioaerogels, and use these bioaerogels to rapidly recognize nitric oxide (NO) through a gas-phase reaction. This type of protocol may aid in the future development of biosensors or other bioanalytical devices.
02:34
Enzymes
0 Views •
2020
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions. Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
04:35
Enzyme Activity - Concepts
0 Views •
2019
Biological Catalysts All living organisms continuously perform numerous biochemical reactions to sustain their presence. Most of these reactions require an input of energy to start, which is called the activation energy. Catalysts are chemicals that lower the activation energy. Even though catalysts facilitate a chemical reaction, they are not consumed by it. This means a catalyst can facilitate a specific chemical reaction over and over in succession, increasing the rate of that reaction.
FAQs
The catalytic cycle depends on electrons delivered by NADPH through a reductase partner. This transfer enables the heme center to activate molecular oxygen and direct one oxygen atom into the substrate. The second oxygen atom is reduced to water. This coupling links cellular electron supply to the oxidation of drugs, hormones, and other chemicals.
Cytochrome P450 Enzymes determine how molecular oxygen is split during oxidation: one oxygen atom becomes part of the substrate, whereas the other is converted to water. This arrangement allows oxidation of drugs, hormones, and other chemicals rather than indiscriminate oxygen transfer. The outcome matters clinically because the resulting metabolism can change exposure, effectiveness, and toxicity.
Genetic variation and liver disease can change P450 activity, so the same administered drug may not be metabolized identically in every patient. Enzyme inhibition or induction adds another source of variability. These differences can modify drug clearance and therefore influence therapeutic effectiveness or toxicity, making patient context important when interpreting pharmacologic responses.
Inhibition tends to reduce enzyme activity, whereas induction tends to increase it. These opposing influences can change the rate at which a drug is cleared. Altered clearance may shift therapeutic effectiveness or toxicity, helping explain why interacting treatments or different patients can show different responses.
P450-mediated metabolism helps clinicians anticipate drug clearance when selecting doses. By considering how variation, liver disease, inhibition, or induction may alter enzyme activity, they can better judge the likelihood of changed therapeutic effectiveness or toxicity. This reasoning supports dose selection and more individualized treatment decisions.
Liver disease is clinically relevant because it can alter P450-mediated metabolism. A change in metabolic activity may affect how quickly drugs are cleared, which can influence therapeutic effectiveness and toxicity. Considering liver status therefore helps clinicians interpret patient responses and assess whether standard expectations may not apply.
Clinical evaluation of P450-mediated metabolism can help connect enzyme activity with meaningful outcomes: drug clearance, therapeutic effectiveness, and toxicity. That information supports prediction of drug interactions and informs safer treatment development. In practice, its value lies in translating biochemical variation into more informed pharmacologic decisions.